Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid - A 3-week multicentre randomized controlled trial (ALADIN Study)

Diabetologia

Volumn 38, Issue 12, 1995, Pages 1425-1433

  Ziegler, D ^a   Hanefeld, M ^b   Ruhnau, K J ^c   Mei\ner H P ^c   Lobisch, M ^d   Schutte K ^d   Gries, F A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c Diabetologische Schwerpunktpraxen   (Germany)

^d ASTA MEDICA AG   (Germany)

Author keywords

anti oxidants; Diabetic neuropathy; symptom scores; treatment; lipoic acid

Indexed keywords

ANTIOXIDANT; PLACEBO; THIOCTIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PLACEBOS; THIOCTIC ACID; TIME FACTORS; TREATMENT OUTCOME;

EID: 0028845524     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00400603     Document Type: Article

References (49)

1. The effect of intensive diabetes therapy on the development and progression of neuropathy
2. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus
3. Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients
4. Effects of pancreatic transplantation on diabetic neuropathy
5. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
6. Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, -kinetic, and -genetic aspects
7. Relative mortality from overdose of antidepressants
8. Mexiletine in the treatment of diabetic neuropathy
9. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study
10. Topical capsaicin in the treatment of painful diabetic neuropathy
11. Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence
12. One-year treatment with the aldose reductase inhibitor, ponal-restat, in diabetic neuropathy
13. Myo-inositol supplementation
14. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals
15. Growth factors and diabetic neuropathy
16. Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies
17. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy
18. Acetyl- l-carnitine for symptomatic diabetic neuropathy
19. Oxygen free radical effects in sciatic nerve in experimental diabetes
20. Effect of α-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve
21. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications
22. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species
23. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat
24. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats
25. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats
26. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids
27. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy
28. 1 bei der diabetischen Neuropathie
29. Graphic representation of pain
30. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population
31. Intention-to-treat analysis and the goals of clinical trials
32. Zur Wirksamkeit der ThioctsÄuretherapie bei Typ-I-Diabetikern
33. Zur medikamentösen Behandlung der diabetischen Polyneuropathie mit der Alpha-LiponsÄure oder Vitamin B-PrÄparaten
34. Quality assessment of randomised clinical trials on medical treatment of diabetic neuropathy
35. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy
36. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients
37. Nerve conduction velocity in diabetes
38. Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function
39. Thioctic acid induces dose-dependent sprouting of neurites in cultured rat neuroblastoma cells
40. The effects of thioctic acid on motor nerve terminals in acrylamide-poisoned rats
41. Effects of lipoic adic in hexacarbon-induced neuropathy
42. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
43. Oxidative damage in neurodegenerative disease
44. Role of oxidative stress in development of complications in diabetes
45. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria
46. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux
47. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy